Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/7

Click to flip

7 Cards in this Set

  • Front
  • Back
16. How does HPV-B19 get trasmitted?

Where does it rep? What do you see if Sickle Cell?
Inhilation of virus particles shed from URI

Bone marrow, see decrease in reticulocyte count
17. Where does HPV-B19 occur most often?

What joints does it affect?

Females or males?

how do you Dx it serologiclly?
In adults, acult onset?

Hands, wrist, ankles,

Females

antiviral IgM to HPV-B19
18. Rubella -
What kind of virus is it?

Where does it rep?

Symptoms?

what age does it affect more?
RNA

lymph nodes

skin rash and joint pain due to Immune complex, lymphadenopathy

Teens, and adults
19. Joint pain in Rubella found in who?

where>
Adult or teen female

wrists, knees, hands, ankle
20. Main risk factor for Hep B?

mediated reaction due to?

What accumulates before clinical manifestations?
Heterosexual Sex, or needles

immune complex

surface antigens found in membrane/envelope of the virus!
21. how do You Dx Hep B?
Urticaria (hives) with polyarthritis
Accompanying signs
History of risk behaviors
Elevated bilirubin and serum transaminases (evidence of liver damage)
Detection of viral antigens and antiviral antibodies in serum
22. How do you treat
HPV-B19
Rubella
Hep B
Treatment- NSAIDS
HPV B-19
No control measures

Rubella
Vaccination
Given 1 and 5 yrs of age
Live attenuated vaccine (MMR)

HBV
Vaccination
Given in 3 doses to infants, adolescents, high risk adults
Recombinant preparation